104 related articles for article (PubMed ID: 12846198)
1. FDA notifications. New dosing option approved for Viracept.
AIDS Alert; 2003 Jul; 18(7):90. PubMed ID: 12846198
[No Abstract] [Full Text] [Related]
2. Twice-daily dosing of Nelfinavir approved.
Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366888
[TBL] [Abstract][Full Text] [Related]
3. FDA notifications. FDA provides more info in response to Viracept recall.
AIDS Alert; 2007 Nov; 22(11):129-31. PubMed ID: 18411458
[No Abstract] [Full Text] [Related]
4. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
James JS
AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
[TBL] [Abstract][Full Text] [Related]
5. New drug approved to treat HIV.
Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
[TBL] [Abstract][Full Text] [Related]
6. New dosing of ddI (Videx) and Nelfinavir (Viracept) approved.
Highleyman L
BETA; 1999; 12(4):3. PubMed ID: 11367246
[TBL] [Abstract][Full Text] [Related]
7. FDA approves nelfinavir. Food and Drug Administration.
GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
[TBL] [Abstract][Full Text] [Related]
8. Nelfinavir: fourth protease inhibitor approved.
Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
[TBL] [Abstract][Full Text] [Related]
9. FDA notifications. Alternative dosing regimen for atazanavir is approved.
AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
[No Abstract] [Full Text] [Related]
10. Fourth protease inhibitor hits the market.
AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
[TBL] [Abstract][Full Text] [Related]
11. Nelfinavir (Viracept) price increase 4.6 percent.
AIDS Treat News; 1998 Oct; (No 305):3-4. PubMed ID: 11365867
[TBL] [Abstract][Full Text] [Related]
12. FDA notifications. Generic lopinavir/ritonavir approved by FDA.
AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652
[No Abstract] [Full Text] [Related]
13. FDA notifications. FDA approves pediatric dosing for ritonavir.
AIDS Alert; 2005 Nov; 20(11):129-30. PubMed ID: 16365934
[No Abstract] [Full Text] [Related]
14. FDA notifications. FDA approves new Kaletra formulation.
AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
[No Abstract] [Full Text] [Related]
15. FDA notifications. UCB Pharma and FDA issue advisory letter.
AIDS Alert; 2004 Feb; 19(2):22-4. PubMed ID: 15011629
[No Abstract] [Full Text] [Related]
16. Nelfinavir (Viracept).
Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
[No Abstract] [Full Text] [Related]
17. FDA notifications. FDA approves half-strength Kaletra.
AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474
[No Abstract] [Full Text] [Related]
18. Bone appetite--using food to boost your Viracept.
Clay PG
Posit Aware; 2003; 14(4):29. PubMed ID: 12951947
[No Abstract] [Full Text] [Related]
19. FDA notifications. HIV-1 adult treatment guidelines are updated.
AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795141
[No Abstract] [Full Text] [Related]
20. FDA notifications. FDA approves new formulation of Lexiva.
AIDS Alert; 2007 Aug; 22(8):90-1. PubMed ID: 17768778
[No Abstract] [Full Text] [Related]
[Next] [New Search]